TY - JOUR
KW - Analgesics, Opioid
KW - Substance Dependence -- Drug Therapy
KW - Buprenorphine -- Therapeutic Use
KW - Naloxone -- Therapeutic Use
KW - Alaska Natives
KW - Native Americans
KW - Medication Compliance -- Evaluation
KW - treatment duration
KW - Human
KW - Alaska
KW - Record Review
KW - Survival Analysis
KW - Descriptive Statistics
KW - Age Factors
KW - Confidence Intervals
KW - Adolescence
KW - Adult
KW - Middle Age
KW - Female
KW - Male
AU - Kate M. Lillie
AU - Jennifer Shaw
AU - Kelley J. Jansen
AU - Michelle M. Garrison
A1 - 
AD - Southcentral Foundation, 4085 Tudor Centre Drive, Anchorage, AK; University of Washington, 4333 Brooklyn Ave NE, Seattle, WA
BT - Journal of Addiction Medicine
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 4
CY - Baltimore, Maryland
DO - 10.1097/ADM.0000000000000757
IS - 4
JF - Journal of Addiction Medicine
LA - English
M1 - Journal Article
PB - Lippincott Williams & Wilkins
PP - Baltimore, Maryland
PY - 2021
SN - 1932-0620
SP - 297
EP - 302
EP - 
T1 - Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People
T2 - Journal of Addiction Medicine
TI - Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1097/ADM.0000000000000757
VL - 15
VO - 1932-0620
Y1 - 2021
Y2 - Jul
ER -